Diasend said today it inked a cloud-to-cloud deal with Abbott (NYSE:ABT) to connect its LibreLink system to Diasend’s diabetes data management system.
Through the deal, users of Abbott’s FreeStyle Libre flash glucose monitoring systems can integrate data from the device, as well as any other Diasend devices such as insulin pumps, blood glucose monitors or activity trackers, into Diasend’s cloud analytics program.
“At Abbott, we are committed to helping people achieve their best health so we strive to give our customers access to the best possible products and services to help them better manage their diabetes. Our collaboration with Diasend is one more step in that direction and we are excited to bring our customers even closer together with their physicians,” Abbott new product innovation director Eric Davis said in a press release.
The system linking requires a compatible Google (NSDQ:GOOG) Android smartphone device with Abbott’s LibreLink app, the companies said. Glucose levels are read by scanning the sensor with the back of the android phone, and data is automatically populated into the users Diasend account through a cloudbased connection
“We are very excited about the collaboration and the valuable addition that FreeStyle Libre is to our line-up of cloud connections, especially as we note a growing appreciation amongst clinics for passively acquired data. This will make diasend even more functional within both our existing type 1 offering and our upcoming venture into type 2 diabetes,” Diasend CEO Anders Sonesson said in a prepared statement.
In February, Senseonics said it inked a collaborative deal with Diasend to use its diasend Clinic and diasend Personal solutions to analyze data from Senseonics Eversense continuous glucose monitoring system.
Under the agreement, patients and clinicians will be able to use Diasend’s programs to review past Eversense CGM data, as well as insulin pump and activity tracker data, the companies said.
